Viemed Healthcare, Inc. (VMD) Earnings Call Transcripts

Viemed Healthcare, Inc.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Viemed Healthcare reported revenue of $75.4 million, reflecting a robust 28% year-over-year growth. The company maintained its earnings at $2.6 million, or $0.06 per diluted share, consistent with the previous year despite a nonrecurring gain in Q1 2025. Management raised the lower end of its full-year revenue guidance to a range of $312 million to $320 million, indicating positive momentum across its sleep, maternal health, and ventilation segments, which could drive future stock performance.

Reported metrics

Guidance from management

Management raised the lower end of its full-year revenue guidance to $312 million to $320 million and reaffirmed adjusted EBITDA guidance of $65 million to $69 million, indicating confidence in continued growth across all segments.

What management said

And I'll add, I think you were specifically talking about maternal. What I would say is people on the sales front is not the governor. It's really back office and fulfillment that we're staffing up on. We have contracts in place, and we have marketing abilities around the country. So it's really about getting the mid and the back office scaled up, and we've already increased that business dramatically. So we're hirin...

Well, we appreciate everyone's trust in our business. We're going to continue to double down on all this growth and positive momentum and look forward to update you guys in the coming quarters. So thanks again for your trust, and have a good day. Thank you.

What analysts pressed on

Analysts expressed concerns about the scalability of the maternal health segment and potential limitations in staffing and fulfillment capabilities. They also inquired about the sustainability of operational efficiencies and whether there are remaining areas for cost reduction.

Main topics on the call

• Revenue Growth — Viemed achieved first quarter revenue of $75.4 million, up 28% year-over-year, matching the record performance from the previous quarter. Management stated, "Q1 carries a predictable seasonal pattern and the business exe...
• Free Cash Flow Improvement — Free cash flow improved significantly to $2.6 million from negative $5.7 million in Q1 2025, marking an $8.3 million year-over-year improvement. This reflects stronger operational cash generation and reduced capital expe...
• Maternal Health Expansion — The maternal health segment is performing ahead of expectations, servicing nearly 4,000 new patients in markets previously unserved. Management noted, "The early results are exceeding our expectations," highlighting the ...
• Ventilation Segment Dynamics — New patient start-up momentum in the ventilation segment is building faster than anticipated, with March seeing 759 setups compared to 692 a year ago. Management emphasized that this is not a demand issue but rather a co...

Read the full Viemed Healthcare, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 30 Viemed Healthcare, Inc. earnings call transcripts on record, spanning March 3, 2020 to August 4, 2026. Based on this history, Viemed Healthcare, Inc. reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

VMD

Exchange

NasdaqCM

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

30

First call

March 3, 2020

Most recent

August 4, 2026

Reporting cadence

quarterly